CAXTON CORP - Q3 2021 holdings

$123 Million is the total value of CAXTON CORP's 55 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 22.2% .

 Value Shares↓ Weighting
CRDF BuyCARDIFF ONCOLOGY INC$16,797,000
+7.8%
2,522,083
+7.6%
13.61%
+27.5%
SBBP SellSTRONGBRIDGE BIOPHARMA PLC$16,370,000
-31.8%
8,024,542
-0.7%
13.27%
-19.4%
MTEM  MOLECULAR TEMPLATES INC$14,346,000
-14.2%
2,137,9910.0%11.63%
+1.5%
SRRA SellSIERRA ONCOLOGY INC$9,705,000
+12.3%
442,754
-0.3%
7.86%
+32.8%
SVRA BuySAVARA INC$9,517,000
-5.9%
6,896,551
+15.9%
7.71%
+11.3%
SCYX BuySCYNEXIS INC$8,291,000
-24.3%
1,564,400
+5.1%
6.72%
-10.5%
GLD  SPDR GOLD TR$6,703,000
-0.9%
40,8200.0%5.43%
+17.3%
KALA BuyKALA PHARMACEUTICALS INC$4,527,000
-49.9%
1,727,751
+1.3%
3.67%
-40.7%
RZLT  REZOLUTE INC$3,173,000
-47.6%
424,2430.0%2.57%
-38.0%
CTIC SellCTI BIOPHARMA CORP$2,950,000
-49.0%
1,000,000
-56.8%
2.39%
-39.7%
ADXN  ADDEX THERAPEUTICS LTDsponsored ads$2,396,000
-5.7%
265,9400.0%1.94%
+11.5%
LUXA  LUX HEALTH TECH ACQUISITION$1,962,000
-0.8%
200,0000.0%1.59%
+17.3%
SPY NewSPDR S&P 500 ETF TRtr unit$1,493,0003,480
+100.0%
1.21%
EFA NewISHARES TRmsci eafe etf$1,482,00019,000
+100.0%
1.20%
AACU  ARES ACQUISITION CORPORATIONunit 99/99/9999$1,383,000
-1.0%
139,6800.0%1.12%
+17.1%
INTU SellINTUIT$1,016,000
+10.0%
1,884
-0.1%
0.82%
+30.0%
GOOG  ALPHABET INCcap stk cl c$992,000
+6.3%
3720.0%0.80%
+25.8%
EIGR BuyEIGER BIOPHARMACEUTICALS INC$939,000
-20.5%
140,622
+1.4%
0.76%
-5.9%
SPGI SellS&P GLOBAL INC$880,000
+3.4%
2,072
-0.0%
0.71%
+22.3%
FB SellFACEBOOK INCcl a$870,000
-2.5%
2,565
-0.0%
0.70%
+15.4%
CVNA SellCARVANA COcl a$870,000
-0.2%
2,886
-0.1%
0.70%
+18.1%
MSFT SellMICROSOFT CORP$862,000
+4.0%
3,057
-0.1%
0.70%
+23.1%
MCO SellMOODYS CORP$845,000
-2.1%
2,380
-0.1%
0.68%
+15.9%
NFLX BuyNETFLIX INC$828,000
+18.8%
1,357
+2.9%
0.67%
+40.4%
CRM SellSALESFORCE COM INC$810,000
+11.0%
2,986
-0.1%
0.66%
+31.2%
PYPL SellPAYPAL HLDGS INC$796,000
-10.8%
3,058
-0.1%
0.64%
+5.6%
V SellVISA INC$783,000
-4.7%
3,513
-0.1%
0.64%
+12.8%
CHTR SellCHARTER COMMUNICATIONS INC Ncl a$772,000
+0.8%
1,061
-0.1%
0.63%
+19.2%
TDG SellTRANSDIGM GROUP INC$773,000
-3.6%
1,238
-0.1%
0.63%
+14.0%
AMT SellAMERICAN TOWER CORP NEW$768,000
-1.8%
2,894
-0.1%
0.62%
+16.0%
MA SellMASTERCARD INCORPORATEDcl a$759,000
-4.9%
2,184
-0.0%
0.62%
+12.4%
DIS SellDISNEY WALT CO$744,000
-3.8%
4,397
-0.1%
0.60%
+13.8%
WHR SellWHIRLPOOL CORP$711,000
-6.6%
3,488
-0.1%
0.58%
+10.6%
MDLZ SellMONDELEZ INTL INCcl a$700,000
-6.9%
12,038
-0.1%
0.57%
+10.1%
FLAC  FRAZIER LIFESCIENCES ACQU CO$629,000
+0.6%
64,0000.0%0.51%
+19.2%
SSAAU  SCIENCE STRATEGIC ACQ ALPHAunit 01/20/2026$618,000
+0.3%
62,0000.0%0.50%
+18.7%
BTWN  BRIDGETOWN HOLDINGS LTD$615,000
-3.0%
62,6880.0%0.50%
+14.7%
HMCOU  HUMANCO ACQUISITION CORPunit 12/08/2023$592,000
-1.0%
57,7240.0%0.48%
+17.1%
FICO SellFAIR ISAAC CORP$591,000
-20.9%
1,485
-0.1%
0.48%
-6.4%
CDLX SellCARDLYTICS INC$571,000
-33.9%
6,801
-0.1%
0.46%
-21.8%
GIGGU  GIGCAPITAL4 INCunit 99/99/9999$459,000
-0.2%
45,0000.0%0.37%
+18.1%
SWBKU  SWITCHBACK II CORPORATIONunit 99/99/9999$398,000
+0.8%
39,0000.0%0.32%
+19.2%
ELEV BuyELEVATION ONCOLOGY INC$375,000
-30.2%
48,183
+21.7%
0.30%
-17.4%
BOASU  BOA ACQUISITION CORPunit 99/99/9999$337,000
-0.3%
34,0700.0%0.27%
+17.7%
SVFA  SVF INVESTMENT CORP$272,000
-1.4%
27,9000.0%0.22%
+16.4%
PV  PRIMAVERA CAPITAL ACQUIST CO$234,0000.0%24,0000.0%0.19%
+18.8%
SCOAU  SCION TECH GROWTH Iunit 12/17/2025$223,000
-1.8%
22,4100.0%0.18%
+16.0%
PICCU  PIVOTAL INVESTMENT CORP IIIunit 01/28/2028$166,000
-1.2%
16,8000.0%0.14%
+17.4%
HLXA  HELIX ACQUISITION CORP$158,000
-4.2%
16,0090.0%0.13%
+13.3%
RMGCU  RMG ACQUISITION CORP IIIunit 02/08/2026$109,000
-0.9%
11,0000.0%0.09%
+17.3%
NewCAZOO GROUP LTD*w exp 08/26/202$94,00062,500
+100.0%
0.08%
LUXAW  LUX HEALTH TECH ACQUISITION*w exp 11/30/202$77,000
-14.4%
66,6660.0%0.06%0.0%
BTWNW  BRIDGETOWN HOLDINGS LTD*w exp 09/30/202$41,000
-50.6%
39,7730.0%0.03%
-42.1%
FLACW  FRAZIER LIFESCIENCES ACQU CO*w exp 11/30/202$14,000
-46.2%
21,3330.0%0.01%
-38.9%
PVWS  PRIMAVERA CAPITAL ACQUIST CO*w exp 01/19/202$10,000
-23.1%
12,0000.0%0.01%
-11.1%
MRACW ExitMARQUEE RAINE ACQUISITION CO*w exp 12/01/202$0-23,171
-100.0%
-0.02%
RTP ExitREINVENT TECHNOLOGY PARTNERScl a$0-11,000
-100.0%
-0.08%
DGNR ExitDRAGONEER GROWTH OPPORTUN CO$0-11,000
-100.0%
-0.08%
NGAC ExitNEXTGEN ACQUISITION CORPcl a$0-11,000
-100.0%
-0.08%
AJAXWS ExitAJAX I*w exp 10/27/202$0-62,500
-100.0%
-0.08%
ALDX ExitALDEYRA THERAPEUTICS INC$0-11,784
-100.0%
-0.09%
SRNGU ExitSOARING EAGLE ACQUISITION COunit 02/23/2026$0-15,000
-100.0%
-0.11%
ISOSU ExitISOS ACQUISITION CORPORATIONunit 99/99/9999$0-24,000
-100.0%
-0.17%
ONCS ExitONCOSEC MED INC$0-159,935
-100.0%
-0.31%
AJAX ExitAJAX I$0-50,000
-100.0%
-0.34%
ISEE ExitIVERIC BIO INC$0-203,414
-100.0%
-0.88%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-11-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MOLECULAR TEMPLATES INC24Q2 202330.7%
STRONGBRIDGE BIOPHARMA PLC22Q3 202173.1%
GARRISON CAP INC18Q3 20209.9%
BERKSHIRE HATHAWAY INC DEL17Q3 20195.8%
EIGER BIOPHARMACEUTICALS INC17Q3 20221.7%
AGILE THERAPEUTICS INC16Q1 201855.5%
KALA PHARNACEUTICALS INC16Q4 202117.6%
CM FIN INC16Q1 20197.8%
SYNTA PHARMACEUTICALS CORP15Q2 201699.9%
CTI BIOPHARMA CORP14Q4 20218.7%

View CAXTON CORP's complete holdings history.

Latest significant ownerships (13-D/G)
CAXTON CORP Q3 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Addex Therapeutics Ltd.February 14, 2023718,8490.9%
Cardiff Oncology, Inc.February 14, 2023983,6072.2%
Rezolute, Inc.February 14, 20231,860,5185.0%
Xeris Biopharma Holdings, Inc.February 14, 20235,973,3244.4%
CTI BIOPHARMA CORPFebruary 14, 20222,239,3002.3%
Sierra Oncology, Inc.February 14, 20221,119,3227.0%
Strongbridge Biopharma plcSold outJanuary 05, 202200.0%
SUNESIS PHARMACEUTICALS INCSold outFebruary 16, 202100.0%
Alcentra Capital CorpFebruary 14, 20201,005,0007.8%
Garrison Capital Inc.February 14, 20201,223,0967.6%

View CAXTON CORP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-13
SC 13G/A2024-02-13
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G/A2023-02-14
SC 13G/A2023-02-14
SC 13G/A2023-02-14
SC 13G/A2023-02-14

View CAXTON CORP's complete filings history.

Compare quarters

Export CAXTON CORP's holdings